ibipinabant

(4S)-3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-N′-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

(4S)-3-(4-Chlorophényl)-N-[(4-chlorophényl)sulfonyl]-N′-méthyl-4-phényl-4,5-dihydro-1H-pyrazole-1-carboximidamide

(4S)-3-(4-Chlorophenyl)-N′-[(4-chlorophenyl)sulfonyl]-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

(4S)-3-(4-Chlorphenyl)-N-[(4-chlorphenyl)sulfonyl]-N′-methyl-4-phenyl-4,5-dihydro-1H-pyrazol-1-carboximidamid

1H-pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N′-methyl-4-phenyl-, (4S)-

1H-Pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-N′-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N-methyl-4-phenyl-, (4S)-

464213-10-3

ibipinabant

[Wiki]

ibipinabant

ibipinabant

ibipinabantum

O5CSC6WH1T

(4S)-3-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N′-methyl-4-phenyl-4,5-dihydropyrazole-1-carboximidamide

(4S)-5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N′-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide

(E,4S)-N-(4-chlorobenzenesulfonyl)-3-(4-chlorophenyl)-N′-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

(S)-(−)-3-(4-chlorophenyl)-N′-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

(S)-3-(4-chlorophenyl)-N-(4-chlorophenylsulfonyl)-N′-methyl-4-phenyl-4,5-dihydropyrazole-1-carboxamidine

(S)-3-(4-chlorophenyl)-N′-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydropyrazole-1-carboxamidine

(S)-SLV 319

(S,E)-3-(4-chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-N′-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

362519-49-1 (racemic)

4-Chloro-N-[1-[(S)-3-(4-chloro-phenyl)-4-phenyl-4,5-dihydro-pyrazol-1-yl]-1-methylamino-meth-(E)-ylidene]-benzenesulfonamide

4S-(−)-3-(4-chlorophenyl)-N-methyl-N′-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine

BRD-K17023466-001-01-3

Ibipinabant (racemic)

MFCD07370146